Rapilif (Rapaflo)4 Mg – 150 tablet

USD $100.20

Each Rapilif contains 4 mg Silodosin 100 tablets. Used to treat the signs and symptoms of benign prostatic hyperplasia (prostate enlargement).

ATC Classification: G04CA04
Active Ingrediant: Silodosin
Generic Name: Rapilif
Manufacturer: IPCA Lab Ltd
Strength: 4 Mg
Dosage Type: Tablet
Packaging Type: Foil in Box
Contains: 100 Tabs

Out of stock

Examples of Packages sent

Medication Safety Issues

Sound-alike/look-alike issues:

Rapaflo may be confused with Rapamune

Silodosin may be confused with sildenafil, sirolimus



Store at room temperature of 25?C (77?F); excursions permitted to 15?C to 30?C (59?F to 86?F). Protect from light. Protect from moisture.


Adverse Reactions

>10%: Genitourinary: Retrograde ejaculation (28%)

1% to 10%:

Cardiovascular: Orthostatic hypotension (3%; increased in elderly ?65 years up to 5%)

Central nervous system: Dizziness (3%), headache (2%), insomnia (1% to 2%)

Gastrointestinal: Diarrhea (3%), abdominal pain (1% to 2%)

Genitourinary: Prostate specific antigen increased (1% to 2%)

Neuromuscular & skeletal: Weakness (1% to 2%)

Respiratory: Nasal congestion (2%), rhinorrhea (1% to 2%), sinusitis (1% to 2%)

<1%, postmarketing, and/or case reports: Hepatic insufficiency, hypersensitivity reaction, increased serum transaminases, intraoperative floppy iris syndrome, jaundice, pharyngeal edema, priapism, pruritus, purpura, skin rash (including toxic), swollen tongue, syncope, urticaria

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , ,


Dosage Type

Packaging Type


Ipca Lab


There are no reviews yet.

Be the first to review “Rapilif (Rapaflo)4 Mg – 150 tablet”

Your email address will not be published. Required fields are marked *